预防糖尿病的问题与展望-中华中医药杂志

预防糖尿病的问题与展望

单位：福建医科大学附属厦门第一医院厦门市糖尿病研究所;

分类号：

出版年,卷(期):页码：2009,(8):981-984

摘要：

糖尿病的患病率已达到流行的程度,其并发症是导致糖尿病患者致死致残的重要原因。且一旦发展成显性糖尿病,目前还不能治愈,这给世界卫生保健体系带来巨大的压力。现有的研究也证明了糖尿病是可以预防的,但在预防过程中还有许多问题没有解决。文章讨论了目前糖尿病预防措施的不足,分析了中医学在糖尿病预防中的作用及优势,并提出了在生活方式干预的基础上,辅以中医药疗法可能是预防糖尿病的最好预防措施;另外,今后的研究应持续更长的时间,以区分究竟是真正预防了糖尿病的发生,还是只是延缓或是掩盖了糖尿病的发生。

The prevalence of diabetes is reaching epidemic proportions worldwide.Elevated glucose levels and associated increases in blood pressure and dyslipidemia lead to long-term complications including cardiovascular disease,diabetic retinopathy,kidney disease,and nervous system damage.These complications are largely responsible for the great increase in morbidity and mortality seen in diabetes.Unfortunately,once established,diabetes is very diffi cult to treat,and it is currently exerting tremendous pressure on ...

参考文献：

Springer 期刊数据库共找到 1 条

[1]	S.P.Babailov,Yu.G.Krieger. NMR methods for molecular structure studies of paramagnetic lanthanide complexes in solutions. Applications to crown ether compl[J]. Foundations of Physics Letters, 2002,15(1) :580~593.

西文参考文献共找到 19 条

[1]	.National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005, .
[2]	Buchanan T,Xiang A,Peters R,et al. Preservation of pancreatic B-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in highrisk Hispanic women .Diabetes, 2002, 51 :2769-2803 .
[3]	H.C. Gerstein,S. Yusuf,J. Bosch. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial .Lancet, 2006, 368 :1096-1105 .
[4]	Torgerson JS,Hauptman J,Boldrin MNet al. Xenical inthe prevention of diabetes in obese subjects(XENDOS)study:a randomized study of orlistat as an adjunct tolifestyle changes for the prevention of type 2 diabetes inobese patients .Diabetes Care, 2004, 27 :155 .
[5]	Abuissa H,Jones PG,Marso SP,et al. Angiotensin convertingenzyme inhibitors or angiotensin receptor blockers for preven-tion of type 2 diabetes .J Am Coll Cardiol, 2005, 46 :821-826 .
[6]	Touyz RM, Campbell N, Logan A, et al. Lifestyle modifications to prevent and control hypertension .Can J Cardiol, 2004, 20(1) :55-59 .
[7]	Nissen SE,Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes .N Engl J Med, 2007, 356 :2457-2471 .
[8]	Yaturu,S,Bryant,B,Jain,SK. Thiazolidinediones treatment decreases bone mineral density in type 2 diabetic men .Diabetes Care, 2007, 30 :1574~1576 .
[9]	Padwal R, Majumdar SR, Johnson JA, et al. A systematic review of drug therapy to delay or prevent type 2 diabetes .Diabetes Care, 2005, 28 :736-744 .
[10]	Wei jia,Wenyuan Gao and Lina Tang. Antidiabetic herbal drugs officially approved in China .Phytotherapy research, 2003, 17 :1127-1134 .
[11]	JP Liu, M Zhang, WY Wang, S Grimsgaard. Chinese herbal medicines for type 2 diabetes mellitus .Cochrane Database of Systematic Reviews, 2002, (Issue 3) .
[12]	Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 .Diabetes Care, 2004, 27 (5) :1047-1053 .
[13]	Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance .New England Journal of Medicine, 2001, 344 (18) :1343-1350 .
[14]	Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin .New England Journal of Medicine, 2002, 346 (6) :393-403 .
[15]	Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial .Lancet, 2002, 359 (9323) :2072-2077 .
[16]	Goldstein DJ. Beneficial health effects of modest weight loss .Int J Obes Relat Metab Disord, 1992, 16 (6) :397-415 .
[17]	Stratton I M,Adler A I,Neil A W,et al. UK Prospective Diabetes Study Group.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35):prospective observational study .BMJ, 2000, 321 :405-421 .
[18]	Hooper L,Summerbell C D,Higgins J P T,et al. Reduced or modified dietary fat for preventing cardiovascular disease(Cochrane Review) .The Cochrane Library, 2004, .
[19]	MorimotoY,Sakata M,Ohno A,et al. Effects of Byakko-ka-ninjin-to,Bofu-tsusho-san and Gorei-san on blood glucose level,eater intake and urine volume in KKAy mice .Yakugaku Zasshi, 2002, 122 :163-168 .

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录